BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12965071)

  • 1. Efficacy and safety of intraprostatic temperature-controlled microwave thermotherapy in patients with benign prostatic hyperplasia: results of a prospective, open-label, single-center study with 1-year follow-up.
    Gravas S; Laguna MP; de la Rosette JJ
    J Endourol; 2003 Aug; 17(6):425-30. PubMed ID: 12965071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
    Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
    J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
    Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
    Urology; 2004 Oct; 64(4):698-702. PubMed ID: 15491704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback microwave thermotherapy versus TURP for clinical BPH--a randomized controlled multicenter study.
    Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
    Urology; 2002 Aug; 60(2):292-9. PubMed ID: 12137829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
    Mattiasson A; Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund-Jacobsen J; Kroyer K; Ageheim H
    Urology; 2007 Jan; 69(1):91-6; discussion 96-7. PubMed ID: 17270624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
    Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
    Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
    Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave thermotherapy for benign prostatic hyperplasia.
    Hoffman RM; Monga M; Elliot SP; Macdonald R; Wilt TJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004135. PubMed ID: 17943811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeking evidence that cell kill guided thermotherapy gives results not inferior to those of transurethral prostate resection: results of a pooled analysis of 3 studies of feedback transurethral microwave thermotherapy.
    Gravas S; Laguna P; Ehrnebo M; Wagrell L; Mattiasson A; de la Rosette JJ
    J Urol; 2005 Sep; 174(3):1002-6; discussion 1006. PubMed ID: 16094023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment characteristics and inherent prostatic features do not predict patient outcome after high-energy transurethral thermotherapy: a prospective study of prostalund feedback treatment.
    Ferakis N; Skolarikos A; Staios D; Liakouras C; Alivizatos G
    J Endourol; 2006 Dec; 20(12):1075-81. PubMed ID: 17206906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine.
    Kehinde EO; Abul F
    Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Rezūm System Water Vapor Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Dixon C; Cedano ER; Pacik D; Vit V; Varga G; Wagrell L; Tornblom M; Mynderse L; Larson T
    Urology; 2015 Nov; 86(5):1042-7. PubMed ID: 26216644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia.
    Kobelt G; Spångberg A; Mattiasson A
    BJU Int; 2004 Mar; 93(4):543-8. PubMed ID: 15008726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
    Volpe A; Billia M; Quaglia M; Vidali M; Marchioro G; Ceratti G; Sogni F; De Lorenzis E; De Angelis P; Airoldi A; Stratta P; Terrone C
    BJU Int; 2013 Aug; 112(3):386-93. PubMed ID: 23496755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral electrovaporization of the prostate: is it any better than standard transurethral prostatectomy? 5-year follow-up.
    Nuhoğlu B; Ayyildiz A; Fidan V; Ersoy E; Huri E; Germiyanoğu C
    J Endourol; 2005; 19(1):79-82. PubMed ID: 15735389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.